Compare DMRA & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | UPBD |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2020 | 1996 |
| Metric | DMRA | UPBD |
|---|---|---|
| Price | $22.10 | $24.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $46.78 | $27.33 |
| AVG Volume (30 Days) | 478.7K | ★ 1.4M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | ★ 121.48 | N/A |
| EPS | N/A | ★ 1.56 |
| Revenue | N/A | ★ $4,695,061,000.00 |
| Revenue This Year | N/A | $0.34 |
| Revenue Next Year | N/A | $3.31 |
| P/E Ratio | ★ N/A | $15.98 |
| Revenue Growth | N/A | ★ 8.67 |
| 52 Week Low | $16.50 | $14.98 |
| 52 Week High | $34.89 | $25.52 |
| Indicator | DMRA | UPBD |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 69.69 |
| Support Level | $18.03 | $17.74 |
| Resistance Level | $22.27 | N/A |
| Average True Range (ATR) | 1.83 | 1.29 |
| MACD | 0.03 | 0.17 |
| Stochastic Oscillator | 30.13 | 87.52 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.